Emergency contraception (EC), sometimes referred to as "the morning-after pill," is a form of backup birth control that can be taken up to several days after unprotected intercourse or contraceptive failure and still prevent a pregnancy. In 1999, Plan B was the first oral product approved for use in the U.S. as an EC by the Food and Drug Administration (FDA). Since then, more EC products have been approved, and there has been debate over access to EC, particularly over-the-counter availability for teenagers. Many have confused EC with the "abortion pill," but EC does not cause abortion, since it works by delaying or inhibiting ovulation and will not work if the woman is already pregnant. This fact sheet reviews the methods of EC, known mechanisms of action, women's awareness of EC, and current national and state policies affecting EC access.
WHAT IS EC?
Emergency contraception is used as a back-up birth control method to prevent unintended pregnancy after sex in the event of unprotected sex, sexual assault, or a contraceptive failure, such as a condom breaking. There are several methods of EC that are available in the U.S. including progestin-based pills, ulipristal acetate, and copper IUDs ( Table 1) . Unlike the copper IUD, EC pills are not intended for use as a regular contraceptive method. ECs do not terminate a pregnancy.  ella is a single-dose pill that is effective in preventing pregnancy up to five days after unprotected intercourse, giving women a longer timeframe to prevent unintended pregnancy than Plan B. 6 Its mechanism of action is similar to that of progestin-based EC.
7
 Study findings show that side effects for ella are comparable to those for Plan B and some research suggests that its effectiveness appears to diminish at BMI thresholds above 35.
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Combined Pills
 Certain daily oral contraceptive pills can also act as EC when taken in doses four or five times higher than the daily dose, although they are not specifically sold as emergency contraception. Oral contraceptive pills contain progestin and estrogen and are taken in two doses 12 hours apart to be effective as EC.
9
 Combined pills have been found to be safe and effective for preventing pregnancy within 5 days of intercourse.
Copper-T IUD: Paragard
 Available to women since the 1970s, Copper-T IUDs are the most effective forms of EC, reducing the risk of pregnancy by more than 99% when inserted within 5 days of unprotected intercourse. 10 IUDs are inserted into the uterus by a health care provider and require a visit to a clinic or provider's office. They also can be used to effectively prevent subsequent pregnancy for up to 12 years.
 The hormone-free Copper-T IUD works by interfering with egg fertilization by preventing sperm from reaching the egg. Previous research suggests the copper IUD inhibits implantation of a fertilized egg, but this mechanism of action has not been conclusively proven.
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 Efficacy of copper IUDs does not diminish in women who are overweight or obese.
 Progestin-based hormone IUDs, such as Mirena and Skyla, are not effective as EC.
WOMEN'S KNOWLEDGE AND USE OF EC
There have been numerous public health and educational initiatives to increase awareness and use of EC.
 
ACCESS AND AVAILABILITY
At least one form of oral EC has been available in the U.S. for over a decade and there have been a number of efforts to broaden women's access to EC, particularly since its effectiveness window is timelimited. 
Over the Counter Access of EC Pills
18
 A prescription is still required for ella for women of all ages.
Cost and Coverage
 The Affordable Care Act (ACA) requires most new private health plans to cover without cost-sharing all FDA-approved contraceptive drugs and devices as prescribed, including ella. 19 Private insurance plans and state Medicaid expansion programs must also cover the cost of IUDs, as well as services related to insertion, follow up and removal, without cost-sharing.
 Family planning services is a required benefit under Medicaid. The coverage requirements under Medicaid are different for states that have expanded eligibility under the ACA. These programs must cover all prescribed FDA approved contraceptives for women with a prescription, meaning that they  Delaware, Illinois, Maryland and Oregon (starting January 2019) require health insurance plans to cover over-the-counter contraceptives without any cost-sharing, including EC.
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 Without a prescription, women in most states accessing EC over the counter must pay the retail price.
Plan B pills and the generic versions sell for between $35 and $60 when purchased over the counter.
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Ten states -AK, CA, HI, MA, ME, NH, NM, TN, VT, WA -have laws that allow pharmacists to directly prescribe progestin based EC to women of all ages without obtaining a physician's prescription.
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 Some studies show that progestin-based EC pills are not consistently stocked on store shelves, and are sometimes kept behind the counter or a locked display due to the high cost of the product. State Policies Requiring Emergency Rooms to Provide Information About Emergency Contraception or Dispense EC Upon Request NOTES: In CT, a hospital may contract with an independent medical professional in order to provide the emergency contraceptive services. OH's law does not include an enforcement mechanism. Hospitals in PA may refuse based on religious or moral beliefs to provide emergency contraception when requested by a woman who has been sexually assaulted; however, a refusing hospital is then required to immediately transport the woman to the closest medical facility that will provide her with the medication. documented that a sizable share of hospitals do not routinely offer counseling, referral, or dispensation of EC to sexual assault survivors.
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Availability and Access in Pharmacies
 AK, CA, HI, ME, MA, NH, NM, TN, VT, and WA also allow pharmacists to prescribe ella ® to women.
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This enables women with private insurance to obtain them directly from the pharmacy without paying any cost-sharing, as is required by the contraceptive coverage provisions of the Affordable Care Act.
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 A 2014 report found that Native American women lacked consistent access to OTC EC pills through Indian Health Services (IHS Since EC first came to market in the U.S., awareness among women of EC pills has risen and availability has expanded as a result of the FDA granting over-the-counter status for progestin based EC pills. One in five women in the U.S. report that they have used EC. Almost 20 years after EC pills were first approved by the FDA, access to EC is still debated heavily by policymakers at both the state and federal levels and will likely continue to be a focus of policy discussions in the years to come.
